Drug Trial Radar · NCT01613963
Causes of Visual Loss in Retinal Disease
Last checked: Nov 20, 2026Latest source record: Jun 7, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,000
Planned (sponsor's estimate)
Start
May 2012
Primary completion
Dec 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- Royal Surrey County Hospital NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 7, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study of visual outcomes in retinal disease that seeks to identify the causes of visual loss. This data will be used to predict which patients are at risk of losing vision and how they can be better treated.
Conditions
- Uveitis
- Scleritis
Interventions
Immunosuppressive AgentsDrug
Treatment with systemic corticosteroids and/or immunosuppressive agents Treatment with local corticosteroids and other drugs
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual acuity at 5 yearsTime frame: 5 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Moorfields Eye Hospital
London, London, United Kingdom
Royal Surrey County Hospital
Guildford, UK, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.